Patent details

301248 Product Name: atogepant of een farmaceutisch aanvaardbaar zout daarvan

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301248
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2638042
Status:
SPC granted but not yet in force
Application number:
301248
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/23/1750
Marketing Authorization Type:
EEA
Marketing Authorization Date:
14/08/2023
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
31/10/2023
First Marketing Authorization date:
14/08/2023
Grant date:
20/11/2023
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
01/11/2023
SPC/SPC Extension Expiration Date:
09/11/2036
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
31/10/2023
 
 

 

Name:
Merck Sharp & Dohme LLC
Address:
126 East Lincoln Avenue, 07065, Rahway, New Jersey, United States of America (US)

Agent

Name:
ir. H.A. Witmans c.s.
From:
31/10/2023
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
47/23
Publication date:
22/11/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
45/23
Publication date:
08/11/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
30/11/2031
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
20/11/2023 Outgoing Correspondence Decision grant 1 PDF /4/7/7/9/3/0800939774/docs/301248_7_576930l504a.pdf
20/11/2023 Certificate Certificate 1 PDF /4/7/7/9/3/0800939774/docs/301248_8_spcmedcertificate20231120131729310.pdf
02/11/2023 Outgoing Correspondence Confirmation receipt request 2 PDF /4/7/7/9/3/0800939774/docs/301248_0_574132l174.pdf
31/10/2023 SPC Documents Summary of the characteristics of the product 13 PDF /4/7/7/9/3/0800939774/docs/301248_1_supplprotectioncertificate20231101110249074.pdf
31/10/2023 SPC Documents Annex SPC 2 PDF /4/7/7/9/3/0800939774/docs/301248_2_supplprotectioncertificate20231101110249117.pdf
31/10/2023 SPC Documents Annex SPC 19 PDF /4/7/7/9/3/0800939774/docs/301248_3_supplprotectioncertificate20231101110249142.pdf
31/10/2023 SPC Documents Marketing Authorization SPC 3 PDF /4/7/7/9/3/0800939774/docs/301248_4_supplprotectioncertificate20231101110249032.pdf
31/10/2023 SPC Documents Annex SPC 3 PDF /4/7/7/9/3/0800939774/docs/301248_5_supplprotectioncertificate20231101110249167.pdf
31/10/2023 Application Form First filed application form 3 PDF /4/7/7/9/3/0800939774/docs/301248_6_applicationform20231101110248943.pdf